Ligand validation:4YVN

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YVN_EDO_A_605	91%	80%	0.086	0.974	0.46	0.39	-	-	0	0	100%	1
4YVN_EDO_A_609	70%	82%	0.108	0.925	0.68	0.14	-	-	0	0	100%	1
4YVN_EDO_A_608	65%	72%	0.131	0.934	0.44	0.65	-	-	0	0	100%	1
4YVN_EDO_A_606	62%	81%	0.14	0.933	0.71	0.12	-	-	0	0	100%	1
4YVN_EDO_A_607	29%	72%	0.221	0.88	0.42	0.66	-	-	0	0	100%	1
4AKO_EDO_A_1513	95%	80%	0.067	0.969	0.44	0.4	-	-	0	0	100%	1
4AKQ_EDO_A_1514	82%	80%	0.111	0.965	0.37	0.46	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.